Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT03164005 Recruiting - Obesity Clinical Trials

The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

Obesity
Start date: April 20, 2017
Phase: N/A
Study type: Observational

The investigators will enroll about 120 subjects from the hospital's healthcare center. The investigators will collect the basic informations, blood pressure, body mass index, fasting blood glucose and fasting blood lipids of each subject. The investigators will collect the blood samples and then test them for fasting insulin levels, VEGF-B levels, the gene promoter region methylation status and the genomic protein methylation levels of the VEGF-B gene of the cells´╝îand finally do the statistical analysis.

NCT ID: NCT03163264 Not yet recruiting - Obesity Clinical Trials

The Move Toward Your Goals Intervention

MTG
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The MTG intervention uses a new MTG software tool delivered on tablets to facilitate 5As-based weight management counseling with a health coach and the VA PACT healthcare team to promote goal-setting, behavior change, and weight loss in the primary care (PC) setting. The MTG intervention also includes 10-15 health-coaching calls to the patient over 12 months. As part of a cluster-randomized controlled study, the investigators will randomize 10 PACT teams at the Brooklyn VA to receive either the MTG Intervention or an Enhanced Usual Care control. The primary aim of the study is to explore differences in feasibility, acceptability, and intermediate, behavioral, and weight loss outcomes at 3, 6 and 12 months of 520 patients recruited from the randomized PACTs. Objective: 1) Explore the feasibility and impact of this intervention on intermediate, behavioral, and weight loss outcomes at 3, 6 and 12 months post-intervention when compared to enhanced usual care.

NCT ID: NCT03162978 Recruiting - Obesity Clinical Trials

Sprint to Fitness: Effect of Outcome Expectations on Responses to Interval Exercise Training

Start date: May 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to research the effects of exercising at high intensities for short periods of time on exercise tolerance and motivation.

NCT ID: NCT03162913 Not yet recruiting - Obesity Clinical Trials

The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults

Start date: July 2017
Phase: N/A
Study type: Interventional

This study is being conducted to assess the effect of dietary strawberry supplementation on cognition and mobility in obese middle-aged and older adults. It is hypothesized that plant compounds, present in strawberries, may improve cognition and mobility.

NCT ID: NCT03158805 Recruiting - Obesity Clinical Trials

Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)

Start date: April 26, 2017
Phase: Phase 2
Study type: Interventional

Taken together these data support the hypothesis that liraglutide 3.0 mg sc injection will reduce body weight and improve metabolic variables in obese or overweight patients with BP without worsening psychiatric symptoms. The investigators predict that liraglutide 3.0 mg sc injection will display greater efficacy as compared to placebo in decreasing body weight in patients with BP who are obese or overweight. To prove this hypothesis, investigators will conduct a single-center, randomized, placebo-controlled, double-blind, parallel-group, 2-arm clinical trial of liraglutide 3.0 mg sc injection in 60 obese or overweight outpatients with stable BP. The investigators have chosen BP rather than another SMI because it is the most common SMI (more common than schizophrenia or schizoaffective disorder) and has a particularly strong association with obesity.

NCT ID: NCT03157778 Not yet recruiting - Obesity Clinical Trials

Relation Between Pregnenolon Endocannabinoids in Normal-weight and Obese Men

CannaPREG
Start date: July 2017
Phase: N/A
Study type: Interventional

Measured plasmatic concentration of pregnenolon and endocannabinoid in fasting conditions and over a meal in obese and normal-weight men subjects, to research a dysfunction in the negative feed-back between pregnenolon and CB1 ligand in obese subjects. This dysfunction could participate to the hyperactivity of endocannabinoid system saw in obesity.

NCT ID: NCT03155880 Completed - Obesity Clinical Trials

Obesity Heterogeneity Study

Start date: January 2011
Phase: N/A
Study type: Observational

The investigators will assess the heterogeneity of obese individuals in the United States to help researchers, clinicians and policymakers to establish goals for obesity treatment and identify whether differing interventions may be needed.

NCT ID: NCT03154593 Recruiting - Obesity Clinical Trials

Prevalence of Chronic Oedema in Obese Patients

Start date: August 2016
Phase: N/A
Study type: Observational

Persistent swelling (chronic oedema), e.g. of the legs, is quite a common condition, which can cause a number of problems, including infections (cellulitis) in the swollen area and ulceration. It seems to be particularly common in people who are overweight but this has not been studied in detail. This study aims to address this gap in knowledge. It will take place in two stages, running in parallel to each other with different groups of patients. The first stage will determine how common persistent swelling is among patients attending weight management services at the Royal Derby Hospital and how it impacts on every day life. The second stage will determine whether weight loss surgery improves the swelling. The results will inform future treatment guidelines for overweight patients who have swelling. They will also inform the design of future research that will investigate the effects of weight loss surgery in more detail, for example by testing out methods of measuring fluid changes in the legs. All new patients attending the weight loss service will be eligible to take part in the first stage of the study, as long as they: give their informed consent to take part, and can speak English (or have someone with them who speaks English). Participants will not have had weight loss surgery previously. The Stage 1 assessment is expected to take about 40 minutes and consists of: a single clinical assessment for each participant to identify the presence of the swelling and its degree in each of the affected areas and, up to 3 questionnaires concerning their quality of life and mobility. Patients attending the programme, who have been referred for bariatric surgery, will take part in the second stage of the study. Stage 2 will last approximately 13 months, during which time the participants will be assessed 4 times - once before surgery and at 3, 6, and 12-month intervals after surgery. Each Stage 2 assessment is expected to take about 50 minutes and consists of: a clinical assessment and up to 5 questionnaires.

NCT ID: NCT03154255 Not yet recruiting - Obesity, Childhood Clinical Trials

GOOD-DAY TRIAL IN PAEDIATRIC OBESITY

GOOD-DAY
Start date: May 15, 2017
Phase: N/A
Study type: Interventional

Alongside efforts in public health and policy to reverse the childhood obesity epidemic, medical providers seek to play effective roles in prevention and treatment. Limited interventional studies with effective long-term maintenance of weight loss in children are available. Moreover, interventions should focus on modifying lifestyle, by improving also ludic educational training. In fact, the knowledge, attitudes, behaviors and skills developed through effective health programs may result in a better quality of life and empower children to make correct choices to promote the health of the individual the family and the community. For this reason, in a cohort of obese pediatric subjects with visceral adiposity, the aim of the study is to assess the efficacy of an educational training inspired to Mediterranean diet and based on gamification (as "The Mediterranean Goose") with respect to a conventional treatment on weight loss and improvement of cardio-metabolic risk factors.

NCT ID: NCT03152617 Recruiting - Obesity, Morbid Clinical Trials

BASUN - Risks for Malnutrition, Metabolic Bone Disease and Impaired Oral Health After Obesity Treatment

BASUN
Start date: April 2015
Phase: N/A
Study type: Observational [Patient Registry]

Weight-reducing obesity surgery (OS) generally gives good results but complications are common; e.g. impaired weight loss, weight regain, bowel pain, diarrhea, vitamin/mineral deficiency, osteoporosis and impaired dental health. The BASUN study is a prospective 10-year comparison of 1000 surgically and 400 conventionally treated individuals regarding adverse side-effects, risk factors for complications and poor outcome.